Trial intelligence / Profile preview

Chewing vs Oral Ticagrelor in STEMI

NCT02725099Phase 4Completed

Sponsor
Sheba Medical Center
Start
May 2016
Primary completion
Jan 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of ticagrelor in ST elevation myocardial infarction (STEMI), sponsored by Sheba Medical Center. Started May 2016; status: completed.

02

Drugs

ticagrelor
03

Conditions

ST elevation myocardial infarction (STEMI)

Beyond the preview

Go deeper on NCT02725099.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02725099.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call